Overview
Specifications
| Reagent | PULSin® |
|---|---|
| Molecule delivered | Protein; Antibody; Peptide |
| Cell types | Adherent & suspension cells grown in presence of serum |
| Number of transfection | 0.4 ml of PULSin® delivery reagent is sufficient to perform 25 delivery experiments in 6-well plates and 100 experiments in 24-well plates |
| Storage | Store PULSin® at 5 °C ± 3°C. Do not freeze. |
| Provided with | Hepes Buffer (20mM) for protein dilution; R-Phycoerythrin used as a positive control |
Summary
The delivery of protein and antibody using PULSin® represents a powerful approach for functional studies. For example, PULSin® enables you to study lethal proteins by controlling the level and time course of protein delivery into the cells. Similarly, delivery of blocking antibodies may provide additional information to traditional RNA interference experiments*. With PULSin® you can target intracellular proteins with antibodies in living cells without fixation step.
* G. Cassinelli et al. (2006). Inhibition of c-Met and prevention of spontaneous metastatic spreading by the 2-indolinone RPI-1, Mol Cancer Ther 5:9, 2388-2397.
Ordering information
| Reference number | Amount of reagent | Positive control (R-phycoerythrin) | Hepes dilution buffer |
|---|---|---|---|
| 101000010 | PULSin® 0.4 mL | 20 µg | 20 ml |
Description
Efficient delivery of proteins/antibodies and peptides to the cytoplasm
Proteins
PULSin® is able to deliver R-phycoerythrin, a fluorescent protein (240 kD), to the cytoplasm of up to 98% cells. As shown in Figure 1, the protein is evenly distributed in the cytoplasm and excluded from the nucleus due to its large size.
Fig 1: PULSin®-mediated intracellular delivery of R-phycoerythrin to NIH-3T3 cells. R-phycoerythrin (1 µg) is complexed with 4 µl of PULSin® for 15 min and added to NIH-3T3 cells in a 24-well plate. Live cells are observed by fluorescence microscopy after 16 h.
Antibodies
Antibodies are also successfully delivered to HeLa cells and able to recognize their target protein inside the cytoplasm.
For example, PULSin® permits the delivery of FITC-labeled anti-alpha-tubulin to the cytoplasm of 85% HeLa cells (Fig.2). Similarly, anti-giantin Alexa Fluor® 488 is delivered to the cytoplasm of 98% of live HeLa cells, labeling the Golgi apparatus (Fig.3).
|
Fig 2: Delivery of a fluorescein-conjugated anti-alpha-tubulin antibody with PULSin® to HeLa cells. |
Fig 3: Golgi labeling (green) of HeLa cells 24 h after delivery of 1 µg Alexa Fluor® 488 anti-Giantin using PULSin®. |
Plasma membrane is stained with ConA-rhodamine. Cells are observed by confocal microscopy.
Peptides
Peptides are biomolecules acting with high specificity at low concentrations. The delivery of substrate, inhibitor, modulator, or blocking peptides into cell allows protein function studies as well as the development of therapeutic approaches. PULSin® is able to successfully deliver Streptococcus TPE B epitope into HeLa cells (Fig. 4).
Fig 4: Delivery of Pep-A (Streptococcus TPE B epitope, 16 aa), into HeLa cells. Complexes are formed with Pep-A (1 µg, lissamine-rhodamine derivative, Sigma) and PULSin® (4 µl). Observation is carried out 16 h post-delivery.
Other proteins, antibodies and peptides can also be delivered to cells using PULSin® (Table 1).
Table 1: Examples of proteins, antibodies and peptides delivered to cells using PULSin®
PULSin® is easy to use and fast
PULSin® will save you time and efforts compared to other techniques using viral transduction or chemical conjugation. PULSin® reagent is ready-to-use and provided with a dilution buffer and a fluorescent control protein (R-phycoerythrin).
The protocol is fast: simply add the reagent to the protein, incubate and add to the cells.
Cells can be analyzed starting 4 hours post-delivery.
Fig 5: PULSin® – Protocol
Delivery to a wide variety of cells
PULSin® is able to deliver proteins and antibodies to a large variety of cell lines and primary cells (Table 2, Fig. 1-3).
Table 2: Efficiency of R-phycoerythrin delivery using PULSin® in selected cells.
Highly efficient transfer
The comparison of PULSin® with two other protein delivery reagents shows a higher efficiency of protein delivery (Fig. 5). Moreover, the amount of protein delivered per cell is higher with PULSin® as measured for R-phycoerythrin protein and for FITC-alpha-tubulin antibody (Fig. 6).
Fig 6: Comparison of PULSin® efficiency with two other protein delivery reagents. R-phycoerythrin (1 µg) is complexed with each reagent according to the manufacturer’s protocol. Complexes are added to HeLa cells and observed by fluorescence microscopy over 24 hours.
Fig 7: FACS analysis of HeLa cells after delivery of R-phycoerythrin (upper graph) or FITC-anti-alpha-tubulin antibody (lower graph) with PULSin® or with competitor reagents B and C. Data are presented as histograms of the mean intensity of fluorescence for each cell population.
Mechanism of delivery
PULSin® contains a proprietary cationic amphiphile molecule that forms non-covalent complexes with proteins and antibodies.
Complexes are internalized via anionic cell-adhesion receptors and are released into the cytoplasm where they disassemble. The process is non-toxic and delivers functional proteins.
FAQ
If you have any questions regarding PULSin®, please visit our dedicated Frequently asked questions or contact us.
Applications
Protein delivery
The intracellular delivery of proteins to live cells offers a powerful alternative as a scientific research tool where other approaches (DNA transfection, RNAi transfection) have failed.
Antibody delivery
The ability to introduce antibodies to live cells opens new insights to a wide range of applications such as protein intracellular trafficking studies, protein interference studies with blocking antibodies, live immunolabelling or protein phosphorylation states studies.
📰 Read Application note: Improving expression and purification of mAb using FectoCHO® Expression System and MabXpure™.
Quality
Every batch of PULSin® is tested by delivering R-phycoerythrin into HeLa cells.
PULSin® is provided as an aqueous solution in sterile and apyrogenic water. PULSin®, R-phycoerythrin and Hepes buffer are shipped at 4°C, should be stored at 4°C upon arrival, and as guaranteed by the Certificate of Analysis, will be stable for at least one year when stored appropriately.
Polyplus-transfection® has been awarded ISO 9001 Quality Management System Certification since 2002, which ensures that the company has established reliable and effective processes for manufacturing, quality control, distribution and customer support.
Protocol
In order to download a product protocol or a certificate of analysis, please create an account on Polyplus-transfection® Portal.
Why would you need to create an account?
In this personal area you will have access to:
- Product Protocols
- Certificates of Analysis
- Exclusive webinars/articles
- And surprise features!
Other files
Related blog posts
Bibliography
| Cell Line | in vitro in vivo | Delivered Molecule | Reagent | Results & Citations | |
|---|---|---|---|---|---|
| HEK-293T | in vitro | Protein/Peptide/Antibody | PULSin | Chiu, Y. H. et al. (2010) Mol Pharmacol 77, 497-507 Dominant-negative regulation of cell surface expression by a pentapeptide motif at the extreme COOH terminus of an Slo1 calcium-activated potassium channel splice variant | More details |
| BAEC | in vitro | Protein/Peptide/Antibody | PULSin | Matou-Nasri, S. et al. (2009) Int J Oncol 35, 761-73 Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin | More details |
| Mouse primary hippocampal neurons | in vitro | Protein/Peptide/Antibody | PULSin | Puchkov, D. et al. (2011) Cereb Cortex 21, 2217-32 NCAM/spectrin complex disassembly results in PSD perforation and postsynaptic endocytic zone formation | More details |
| MDA-MB-231 | in vitro | Protein/Peptide/Antibody | PULSin | Wu, D. et al. (2010) J Biol Chem 285, 28643-50 GIPC1 interacts with MyoGEF and promotes MDA-MB-231 breast cancer cell invasion | More details |
| - | in vitro | Protein/Peptide/Antibody | PULSin | Jin, Z. et al. (2012) Trends Biotechnol 30, 394-403 Semiconductor quantum dots for in vitro diagnostics and cellular imaging | More details |
| HaCaT, HeLa | in vitro | Protein/Peptide/Antibody | PULSin | Schneider, M. A. et al. (2011) Cell Microbiol 13, 32-46 Identification of the dynein light chains required for human papillomavirus infection | More details |
| HCC | in vitro | Protein/Peptide/Antibody | PULSin | Bao, D. et al. (2019) Oncogene 38, 5007-5020 Mitochondrial fission-induced mtDNA stress promotes tumor-associated macrophage infiltration and HCC progression | More details |
| HeLa | in vitro | Protein/Peptide/Antibody | PULSin | Seo, JH. et al. (2020) Sci Rep 10, 11183 MTFMT deficiency correlates with reduced mitochondrial integrity and enhanced host susceptibility to intracellular infection | More details |
| HCT 116 | in vitro | Protein/Peptide/Antibody | PULSin | Lee J. et al. (2019) Biochem Biophys Res Commun 519, 29-34 Competitive inhibition by NAG-1/GDF-15 NLS peptide enhances its anti-cancer activity | More details |
| Mouse bone marrow-derived macrophages | in vitro | Protein/Peptide/Antibody | PULSin | Baroja-Mazo, A. et al. (2014) Nat Immunol 15, 738-48 The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response | More details |